Image

Delirium After Cardiac Surgery in Intensive Care Units

Delirium After Cardiac Surgery in Intensive Care Units

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

STUDY SUMMARY

STUDY DESIGN The study will be conducted over twelve months in the Cardiac Intensive Care Unit (ICU) at Hammersmith Hospital, Imperial College Healthcare NHS Trust (ICHT). This study is a mixed methods research design that includes the collection of data through qualitative interviews, quality-of-life questionnaires and patients' medical records.

AIMS

  • Determine the incidence of ICU delirium in ICHT following cardiac surgery
  • Explore the compliance of outcome measures that diagnose ICU delirium
  • Implement a family-focused sensory stimulation programme in the ICU
  • Evaluate its useability and potential impact on patients, families and ICU staff

STUDY POPULATION 30 study participants (12 patients, 12 family members/friends and 6 ICU nurses)

ELIGIBILITY Study eligibility criteria are specific for each care group (patients, family members/friends and ICU nurses).

DURATION 12 months at Hammersmith Hospital, ICHT

Description

DaCsi-ICU is a mixed methods research study including the collection of data from patient's medical notes, interviews and quality of life questionnaires following the study schedule of assessments. This study also involves the implementation of an auditory-visual sensory stimulation package in the cardiac ICU at ICHT to participants enrolled in the study.

Digital photos will be shown continuously at the patient's bedside (8am-8pm) after cardiac surgery and will always have reference to time and date. Additionally, videos will be played throughout the patient's stay in the ICU at least three times per day (timepoints: 9am, 2pm,7pm) and upon participant request. Videos will be also played when participants show signs of ICU delirium to reduce its incidence and improve overall health outcomes. Simultaneously, data from patients' medical records will be routinely collected by the research team (e.g., Confusion Assessment Method-ICU, Richmond Agitation Sedation Scale, etc.) to assess whether patients develop delirium during their stay in the ICU.

Interviews with patients and families/friends will be held on three different occasions. The first one will be on the same day as ICU discharge, the second interview will be on the day of hospital discharge and the third one will be carried out up to a month following hospital discharge during their clinical follow-up appointment. Where possible, family members/friends and patient interviews will be conducted together (dyadic interviewing), but the possibility of performing interviews separately will be given so that participants feel able to discuss opinions freely. Nurses' interviews will be held as a one-off and after they have provided direct care to participants who received the proposed intervention.

Each patient will be followed up daily on the wards and once at the monthly follow-up clinic after ICU discharge, where cognitive and emotional assessments will be performed to evaluate delirium outcomes. The research team will also collect relevant information from participants' medical notes if any complications post-ICU discharge arise during inpatient and follow-up stages.

Eligibility

INCLUSION CRITERIA

Patients

  • Female and male patients over the age of 18
  • Participants speaking English language and having mental capacity to consent
  • Suitable to undergoing cardiac surgery at ICHT.

Family Members/Friends

  • Nominated by the participant.
  • Be willing to record videos and participate in the study.

Healthcare professionals

  • Critical Care Nurses that have provided direct care to at least one patient who received the study intervention

EXCLUSION CRITERIA

Patients

  • Female and male patients under the age of 18
  • Unable to consent to the study pre-operatively
  • Significant hearing/visual impairment
  • Participants with learning disabilities, pre-existing delirium, dementia or other significant underlying cognitive morbidity
  • Moribund participants, likely to die in the next 24 hours
  • Participants that do not speak English language

Family Members/Friends

  • Refuse to consent or gain assent
  • Significant hearing/visual impairment
  • Family members/friends that do not speak English language

Healthcare professionals

  • Critical care nurses that have not been involved in the implementation of the intervention
  • Refuse to consent or gain assent
  • Significant hearing/visual impairment and non-English speaking

WITHDRAWAL CRITERIA:

Participants

  • No longer willing to participate after consent
  • Personal consultee wishing to withdraw participants from the study
  • Patients that the clinical and/or research team deem too distressed to continue participating in the study
  • Patients who have lost the capacity to participate in the study after hospital discharge

Study details
    Intensive Care Unit Delirium
    Cardiac Surgery
    Post Operative Delirium

NCT06355570

Imperial College Healthcare NHS Trust

16 April 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.